HealthTronics, Inc. (HTRN) Announces FDA Clearance and Launch of the New LithoDiamond ULTRA Lithotripter  
5/15/2007 1:30:59 PM

AUSTIN, Texas--(BUSINESS WIRE)--HealthTronics, Inc. (NASDAQ: HTRN), a leading provider of urology services and products, announces the launch of its LithoDiamond ULTRA lithotripter providing an evolution in lithotripsy treatment technology. FDA clearance of the equipment has been granted and over fifty patients have been treated. This platform evolution is the largest advancement in lithotripsy technology in more than a decade and is based on the significant input from our urologist partners and clinicians in the urology community. The LithoDiamond ULTRA has five unique clinical features that define it as the most technologically and clinically advanced lithotripter available in the global marketplace today. These features include: